Cohesins Functionally Associate with CTCF on Mammalian Chromosome Arms  by Parelho, Vania et al.
Cohesins Functionally Associate with
CTCF on Mammalian Chromosome Arms
Vania Parelho,1,8 Suzana Hadjur,1,8 Mikhail Spivakov,1 Marion Leleu,1 Stephan Sauer,1 Heather C. Gregson,6,7
Adam Jarmuz,2 Claudia Canzonetta,3 Zoe Webster,4 Tatyana Nesterova,5 Bradley S. Cobb,1 Kyoko Yokomori,6
Niall Dillon,3 Luis Aragon,2 Amanda G. Fisher,1 and Matthias Merkenschlager1,*
1Lymphocyte Development Group
2Cell Cycle Group
3Gene Regulation and Chromatin Group
4Transgenics Facility
5Developmental Epigenetics Group
MRC Clinical Sciences Centre, Imperial College London, Du Cane Road, London W12 0NN, UK
6Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA 92697, USA
7Present address: Healthcare Diagnostics Group, Focus Diagnostics, Inc., Cypress, CA 90630, USA.
8These authors contributed equally to this work.
*Correspondence: matthias.merkenschlager@csc.mrc.ac.uk
DOI 10.1016/j.cell.2008.01.011SUMMARY
Cohesins mediate sister chromatid cohesion, which
is essential for chromosomesegregation andpostrep-
licative DNA repair. In addition, cohesins appear to
regulate gene expression and enhancer-promoter in-
teractions. These noncanonical functions remained
unexplained because knowledge of cohesin-binding
sites and functional interactors in metazoans was
lacking. We show that the distribution of cohesins
on mammalian chromosome arms is not driven by
transcriptional activity, in contrast to S. cerevisiae.
Instead, mammalian cohesins occupy a subset of
DNase I hypersensitive sites, many of which contain
sequence motifs resembling the consensus for
CTCF, a DNA-binding protein with enhancer blocking
function and boundary-element activity. We find co-
hesins at most CTCF sites and show that CTCF is re-
quired for cohesin localization to these sites. Recruit-
ment by CTCF suggests a rationale for noncanonical
cohesin functions and, becauseCTCF binding is sen-
sitive to DNAmethylation, allows cohesin positioning
to integrate DNA sequence and epigenetic state.
INTRODUCTION
Cohesin complexes consist of Smc1/Smc3 (structural mainte-
nance of chromosomes 1 and 3) heterodimers and two non-
Smc subunits Scc1 (Rad21) and Scc3 (SA1/SA2; Figure S1).
They hold sister chromatids together from the time of DNA
replication in S phase to their segregation in mitosis, and this
function is essential for proper chromosome segregation, post-
replicative DNA repair, and the prevention of inappropriate re-
combination between repetitive regions (Hirano, 2006; Huang
et al., 2006; Kobayashi and Ganley, 2005; Lehmann, 2005; Nas-422 Cell 132, 422–433, February 8, 2008 ª2008 Elsevier Inc.myth, 2005). Cohesins are bound to mammalian chromatin
throughout the cell cycle from telophase to the onset of ana-
phase, and evidence frommodel organisms and human genetics
suggests that, in addition to their primary role in sister chromatid
cohesion, cohesins may function in the control of gene expres-
sion during interphase (reviewed in Hagstrom and Meyer,
2003). For example, reduced expression of either Rad21 or
Smc3 impairs Runx gene expression and consequently impairs
hematopoiesis and nervous-system development in zebrafish
(Horsfield et al., 2007). In Drosophila, Nipped-B/delangin, a ho-
molog of the cohesin loading factor Scc2, is required for the ac-
tivation of the cut and Ultrabithorax homeobox genes, as well as
of genes in the Notch pathway (Rollins et al., 1999). In humans,
developmental abnormalities described as Cornelia de Lange
syndrome are caused by heterozygous mutations in NIPBL
and deletions or missense mutations in the Smc1 homolog
SMC1L1 (Tonkin et al., 2004; Krantz et al., 2004; Strachan,
2005; Musio et al., 2006; Vega et al., 2005). The related Roberts
syndrome is caused by mutations in ESCO2, a homolog of the
S. cerevisiae gene Eco1, which encodes a cohesion-loading pro-
tein (Vega et al., 2005). Deletion of the gene encoding the cohe-
sin cofactor PDS5B in mice also results in severe developmental
abnormalities in the absence of overt defects in sister chromatid
cohesion (Zhang et al., 2007). Themechanisms that link cohesins
to developmental gene regulation remain unclear, but current
models invoke cohesins in the control of interactions between
distant regulatory elements (Rollins et al., 2004; Dorsett, 2006;
Strachan, 2005).
Genome-wide mapping has shown that the position of cohe-
sin complexes on the chromosome arms of S. cerevisiae corre-
lates with transcriptional activity, which appears to reposition
cohesins from their loading sites (Lengronne et al., 2004; Glynn
et al., 2004). As a result, cohesins are highly overrepresented
at the 30 ends of genes and especially within intergenic regions
between convergent transcripts (Lengronne et al., 2004). Be-
yond this inverse correlation with transcription, cohesins localize
to silent chromatin (Bernard et al., 2001; Nonaka et al., 2002;
Chang et al., 2005) and decorate the boundaries between active
and silent chromatin domains in S. cerevisiae and in S. pombe,
where genetic evidence suggests a functional role in the estab-
lishment of such boundaries (Blat and Kleckner, 1999; Donze
et al., 1999; Lau et al., 2002; Laloraya et al., 2000; Hagstrom
and Meyer, 2003).
The importance of cohesins for chromosome biology and their
unexplained involvement in chromatin-mediated gene regulation
(Hirano, 2006; Nasmyth, 2005; Lehmann, 2005; Hagstrom and
Meyer, 2003) prompted us to examine their positioning within
mammalian chromatin. Given the relationship to transcription
(Lengronne et al., 2004; Glynn et al., 2004) and chromatin remod-
eling (Hakimi et al., 2002), we paid particular attention to the
placement of cohesins relative to regulatory elements within
well-studied loci, as well as genome-wide. We find that in con-
trast to yeast, the location of cohesins on mammalian chromatin
is not determined by transcription, but rather by local sequence
context and chromatin structure, with a strong preference for
DNase I hypersensitive sites and conserved noncoding se-
quences. Interestingly, the sequence motif most highly enriched
among mammalian cohesin sites strongly resembles the
consensus for the sequence-specific DNA-binding protein
CTCF (Kim et al., 2007). CTCF is notable for its association
with vertebrate imprinting control regions, insulators, and boun-
dary elements, which are thought to partition the genome into
independently regulated domains (West et al., 2002; Ohlsson
et al., 2001). This sequence similarity led us to explore the coloc-
alization and the functional relationship between cohesin and
CTCF. Most cohesin sites tested were indeed occupied by
CTCF in mouse and human cells, and cohesins were highly en-
riched at the mouse orthologs of known human CTCF sites
(Kim et al., 2007; Barski et al., 2007). The interaction between co-
hesins and CTCF was functional, since siRNA-mediated knock-
down of CTCF abolished cohesin positioning. The preference of
CTCF for unmethylated DNA (Bell and Felsenfeld, 2000; Hark
et al., 2000) suggests an explanation for the existence of cell-
specific cohesin sites. Our findings provide a mechanism for
the positioning of cohesins on mammalian chromosome arms
and a rationale for noncanonical cohesin functions.
RESULTS
Cohesins Bind to a Subset of Constitutive
DNase I Hypersensitive Sites
To map mammalian cohesin sites by chromatin immunoprecipi-
tation (ChIP), we stably transduced lymphoid mouse cell lines
with a FLAG-tagged form of the cohesin subunit Rad21
(2xFLAG-Rad21-IRES-puromycin), which was expressed at
levels similar to endogenous Rad21 (Figure S1A). Silver staining
demonstrated that cohesin subunits were highly enriched by
a single anti-FLAG immunoprecipitation step (Figure S1B), and
immunoblotting showed that FLAG-Rad21 associated with the
cohesin subunits SMC1, SMC3, and SA1 (Figure S1C). The use
of epitope-tagged Rad21 allowed us to routinely control for the
specificity of ChIP using untransfected cells or cells transfected
with control vector (IRES-puromycin).
We began our analysis at the mouse Vpreb1/Igll1 locus, which
is expressed exclusively in immature B lymphocytes (pre-Bcells). The locus contains within 18.3 kb the coding regions for
the surrogate light chain proteins of the pre-B cell receptor, l5
and VpreB1, and the control elements required for their cell
type- and developmental stage-specific expression (Figure 1A)
(Sabbattini and Dillon, 2005). Parallel ChIP experiments were
performed in the pre-B cell line B3, where Vpreb1/Igll1 is ex-
pressed, and in the thymocyte line VL3, where the locus is silent
(Figure 1B, the inset shows qRT-PCR for Igll1 expression). Real-
time PCR (qPCR) identified a single cohesin site at HS1 at the 30
end of the coding region in Igll1 expressing pre-B cells (B3,
Figure 1B). Unexpectedly, cohesin binding to HS1 did not require
Igll1 expression, since it was also detected in Igll1 nonexpress-
ing VL3 cells (Figure 1C). ChIP using a well-characterized Rad21
specific antibody (Hakimi et al., 2002) confirmed the presence
of endogenous Rad21 at HS1 (Figure 1D). ChIP with anti-
Smc3 showed colocalization of Smc3 and Rad21 (Figure 1D).
We also examined primary thymocytes expressing physiological
levels of transgenic HA-tagged Rad21 (Figure S2). Anti-HA ChIP
mapped cohesins to HS1 (Figure 1E), indicating that cohesins
bind to the same site in the Vpreb1/Igll1 locus in lymphoid cell
lines and in primary lymphocytes. The 6 kb region 30 of Igll1 con-
tains five DNase I hypersensitive sites (HSS), which form part of
a locus control region (LCR) that confers copy number-depen-
dent, position-independent expression in pre-B cells (Sabbattini
and Dillon, 2005). HSS 2–5 are present only in pre-B cells (black
vertical arrows in Figure 1A), while HS1 is constitutive (red, ver-
tical arrow in Figure 1A) (Sabbattini and Dillon, 2005). We con-
firmed DNase I hypersensitivity of HS1 in both B3 (expressing)
and in VL3 (nonexpressing) cells (Figure 1F). Hence, cohesins
map to a constitutive HSS at the 30 end of the Vpreb1/Igll1 locus.
We explored the potential association of cohesins and DNase I
hypersensitivity at additional loci that arewell studied at the chro-
matin level and differentially expressed in lymphocyte lineages.
The mouse Cd8 locus contains two transcription units oriented
in the same direction (Figure 2A, black). Its regulatory elements
comprise four clusters of 18 HSS. Clusters II to IV are T cell spe-
cific and have enhancer function; cluster I is constitutive (red,
horizontal bar in Figure 2A) and neither its function nor its associ-
ated proteins are known (Kioussis andEllmeier, 2002) (Figure 2A).
ChIP andqPCR identified aprominent cohesin site atHSScluster
I in CD8-expressing VL3 cells (Figure 2B) and CD8-expressing
primary thymocytes (not shown), as well as in BW5147 thymoma
cells, which do not express CD8 (Figure 2B, inset shows qRT-
PCR for Cd8a RNA). ChIP on chip on genomic tiling arrays pro-
vided independent evidence for cohesin enrichment at cluster I
in Cd8 expressing (VL3, black) and nonexpressing (B3, green)
cells (Figure 2C). The mouse Cd4 locus encompasses a single
transcription unit and a complex arrangement of regulatory ele-
ments marked by 17 HSS (vertical arrows in Figure 2D), including
two 50 enhancers, an intronic enhancer, a developmental stage-
specific enhancer, and an intronic silencer (Figure 2D) (Kioussis
and Ellmeier, 2002). ChIP and qPCR analysis identified cohesin
sites at a subset of constitutive HSS (red, vertical arrows in Fig-
ure 2D), namely at HS2, located between the 50 enhancers and
a set of sites 30 of theCd4 transcription unit at HSS 8/9 andwithin
HSS cluster 11–16 (Figures 2E and 2F). ChIP on chip indepen-
dently demonstrated cohesin enrichment at these sites in Cd4
expressing (VL3, black) and nonexpressing (B3, green) cellsCell 132, 422–433, February 8, 2008 ª2008 Elsevier Inc. 423
(Figure 2F). Collectively, these data show that cohesins map to
a subset of constitutive HSS sites in the mouse Vpreb1/Igll1,
Cd8, and Cd4 loci (Kioussis and Ellmeier, 2002).
Cohesin Binding Is Determined by Local
Sequence Content
To determine whether cohesin-binding elements can recruit co-
hesins to ectopic locations, we analyzed mouse pre-B cells that
contained—in addition to two endogenous copies of Vpreb1/
Igll1—a transgene array consisting of 10–12 Vpreb1/Igll1 copies
integrated into pericentromeric repeat DNA (Lundgren et al.,
2000). Transgenic cells accumulated three to four times more
cohesin at HS1 than nontransgenic control cells (Figure S3).
While these data cannot formally distinguish between endoge-
nous and transgenic copies of the locus, they argue strongly424 Cell 132, 422–433, February 8, 2008 ª2008 Elsevier Inc.Figure 1. Cohesins Bind a Constitutive DNase I Hypersensitive
Site at the 30 End of the Vpreb1/Igll1 Locus Independent of
Gene Expression
(A) Schematic representation of the Vpreb1/Igll1 locus with Topo3b,
Vpreb1, and Igll1 coding regions (black). Vertical arrows represent HSS,
black for cell-type specific and red for constitutive. qPCR primer positions
are indicated by red bars.
(B) Cohesin ChIP of the Vpreb1/Igll1 locus in Igll1 expressing 2xFLAG-
Rad21 B3 cells (gray bars). Vector (IRES-puromycin)-transfected B3 cells
are shown as negative controls (black bars; n = 3 mean ± SD). The num-
bers on the horizontal axis refer to the qPCR primers shown in (A). The
inset confirms differential expression of Igll1 in 2xFLAG-Rad21 B3 pre-B
cells but not in 2xFLAG-Rad21 VL3 thymocytes by qRT-PCR.
(C) Cohesin ChIP in Igll1 nonexpressing 2xFLAG-Rad21 VL3 cells (gray
bars) and control-transfected VL3 cells (black bars; n = 3, mean ± SD).
(D) ChIP of endogenous cohesin subunits in B3 cells using anti-Rad21
(dark gray, n = 2, mean ± standard error [SE]) and anti-Smc3 (light gray,
n = 2, mean ± SE).
(E) Cohesin ChIP in Igll1 nonexpressing Rad21-3HA primary thymocytes
(gray bars) and control thymocytes (black bars, n = 2).
(F) DNase I hypersensitivity of the DHS1 site in B3 (broken green line) and
VL3 cells (broken blue line) cells relative to a control site in the Il4 locus
(solid lines).
for ectopic cohesin recruitment. Importantly, when the
827 bp encompassing HS1 were deleted (dHS1Vpreb1/Igll1)
(Lundgren et al., 2000), cohesins were no longer enriched,
despite similar copy number and comparable integration in
pericentromeric repeat DNA (Figure S3). We conclude that
cohesin binding is determined by local sequence content,
rather than at the level of global genome organization and
that the HS1 sequence mediates cohesin recruitment.
Cohesin Mapping on a Genomic Scale: Relationship
to Genes and Gene Expression
To identify additional cohesin sites,wecombinedChIPwith ge-
nomic tilingarrays representing200kb to2Mbsurrounding120
selected genes and a contiguous section of mouse chromo-
some 17 at 100 bp resolution (approximately 3% of the unique
sequence content of the mouse genome). This approach un-
covered a total of 1844 cohesin sites, 1619 in B3 pre-B cells,
and 1217 in VL3 thymocytes. The majority of sites (889) were
present in both cell types. The spacing of cohesin sites was ir-
regularand,withanaveragedistanceof 22.2 kb,comparable to
that reported for S. cerevisiae (merging sites <3 kb apart, not
shown). Validation of ChIP on chip results was provided by the in-
clusionon thearraysof loci studied indepthbyChIPandqPCR (see
above) and by additional qPCR experiments, which confirmed 47
of 49 sites tested (Figure 3A) (data not shown). qPCR also showed
that 17 of 19 of cohesin sites forwhich tiling arraysdetectedsignals
either in B3pre-B cells or in VL3 thymocyteswere indeedpreferen-
tially or exclusively present in B3 or in VL3 cells (Figure 3A).
We found that 45.6% of cohesin sites overlapped known
genes, while 54.4% were intergenic. This is close to a random
distribution expected based on the representation of genic and
intergenic regions (45.4% and 54.6%, respectively) on our array,
which by design is biased toward gene-rich regions. This indi-
cates that in mouse cells cohesins do not avoid or prefer genes
over intergenic regions (p = 0.904, c2). In S. cerevisiae, cohesins
Figure 2. Cohesins Localize to a Subset of Consti-
tutive HSS within the Developmentally Regulated
Cd4 and Cd8 Loci
(A) Schematic representation of the Cd8 locus with Cd8a-
andCd8b-coding regions (black), qPCR primers used (red
bars), DNase I hypersensitive site clusters (bars, red for
constitutive sites), and regulatory regions (green).
(B) Cohesin localization inCd8 expressing 2xFLAG-Rad21
VL3 cells (gray bars) and control transfected VL3 cells
(black bars; n = 3, mean ± SD). DNase I hypersensitivity
of cohesin sites was confirmed experimentally (not
shown). The inset shows qRT-PCR analysis of Cd8a
expression.
(C) ChIP on chip analysis of the Cd8 locus showing dupli-
cate tracks for B3 cells, which do not expressCd8a (green)
and Cd8a-expressing VL3 cells (black). The vertical axis
shows log2 enrichment, and small rectangles between
tracks indicate cohesin sites as defined by PeakFinder
(Nimblegen).
(D) Schematic representation of theCd4 locus with coding
region (black), DNase I hypersensitive sites (arrows, red for
constitutive sites); distal (DE), proximal (PE), intronic (IE),
and thymocyte enhancers (TE); promoter (Pro) and locus
control region (LCR) in green; and the intronic silencer in
red. The positions of qPCR primers are shown.
(E) Cohesin localization in Cd4-expressing 2xFLAG-
Rad21 VL3 cells (dark gray bars) and CD4 nonexpressing
2xFLAG-Rad21 BW5147 cells (BW, light gray bars).
DNase I hypersensitivity of cohesin sites was confirmed
experimentally (not shown). The inset shows qRT-PCR
analysis of Cd4 expression.
(F) ChIP-on-chip analysis of the Cd4 locus showing dupli-
cate tracks for B3 cells, which do not express Cd4 (green)
and Cd4-expressing VL3 cells (black). log2 enrichment
and cohesin sites are shown as in (C).
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Figure 3. Cohesin Mapping on a Genomic Scale
Cohesin sites were identified by ChIP on chip on 100 bp resolution
genomic tiling arrays.
(A) Cohesin sites present on genomic tiling arrays from both B3
and VL3 cells or either B3 or VL3 cells were validated by qPCR us-
ing Rad-21 ChIP material from B3 (dark gray) or VL3 cells (light
gray). Primer positions are indicated (chromosome and base
count in kilobases).
(B) Mammalian cohesin sites show no preference for convergently
transcribed intergenic sites. The yeast data are from Lengronne
et al., 2004, a slightly lower figure of 84% was given by Glynn
et al., 2004.
(C) The number of intergenic cohesin sites is greatest close to tran-
scription start sites (TSS) and transcription termination sites (TTS)
and declines with increasing distance from genes in B3 pre-B cells
(truncated at 50 kb).are vastly enriched at intergenic regions between convergently
transcribed genes (Lengronne et al., 2004; Glynn et al., 2004).
By contrast, the fraction of cohesin sites located in intergenic re-
gions between convergent, expressed genes in mouse pre-B
cells (13.2%) was slightly below that expected from a random
distribution (15.3%, p = 0.02) (Figure 3B) and similar to the frac-
tion of intergenic sites between genes that are convergent but
silent in mouse pre-B cells (20.1% versus 20.0% expected,
p = 0.9). Cohesins are severely depleted from intergenic sites426 Cell 132, 422–433, February 8, 2008 ª2008 Elsevier Inc.between divergent genes in yeast (2% according to
Glynn et al. [2004]). This was not the case in mouse
cells (25.9% found compared to 26.9% expected).
However, reminiscent of results in yeast, intergenic
cohesin sites in mouse cells were preferentially lo-
cated close to genes, and their frequency declined
with increasing distance from transcription start and
termination sites (Figure 3C). The probability of finding
at least one cohesin site within a gene was similar for
expressed and silent genes (0.54 for the 30% of genes
most highly expressed in B3 pre-B cells and 0.51 for
the 30% of genes with the lowest expression levels
as judged by cDNA expression arrays, not shown).
These data indicate that, unlike in yeast, the position-
ing of cohesins on mammalian chromosome arms
does not correlate with overt transcription.
Cohesin Binding Is Compatible with Locus
Remodeling and High-Level Expression
of Cytokine Genes during T Cell Differentiation
The regulation of cytokine gene expression in helper
T cells (Th) provides an interesting test case for the
relationship between cohesin binding, chromatin
remodeling, and gene expression. Unusually, cytokine
expression is not only cell-type and developmental-
stage specific, but also transient and acutely induced
by cellular activation. Depending on the cytokine mi-
lieu, naive CD4 T cells differentiate toward alternative
lineages, Th1 or Th2 (reviewed by Murphy and Reiner,
2002; Ansel et al., 2003; Lee et al., 2006). During Th1
differentiation, chromatin remodeling prepares the Ifng
locus for expression and silences Th2-specific cy-tokine genes encoding IL-4, IL-5, and IL-13. Conversely, Th2 dif-
ferentiation remodels the region around the Th2 cytokine loci in
preparation for high-level expression and silences Ifng (reviewed
by Murphy and Reiner, 2002; Ansel et al., 2003; Lee et al., 2006).
The Th2 locus encompasses the coding regions for IL-4, IL-13,
and IL-5, as well as a housekeeping gene, Rad50, located
between IL-13 and IL-5. Rad50 encompasses a locus control re-
gion for the Th2 locus. Of 31 HSS, 5 are constitutive (red vertical
arrows in Figure 4A). ChIP analysis in the T cell lines VL3 and
BW5147 and in primary thymocytes found cohesin sites at HSS
RHS-2 and HSS3 (Figure 4A). In the Ifng locus wemapped cohe-
sin to HSII, a constitutive HSS in the first intron of the coding re-
gion in VL3 and BW5147 cell lines and in primary thymocytes
(Figure 4B). The presence of a cohesin site within the Ifng coding
region allowed us to track the fate of cohesins during locus re-
modeling and transcription. Rad21-3HA transgenic naive T cells
were differentiated into Th1 or Th2 cells, which have the potential
for high-level expression of IFNg and IL4, respectively, upon ac-
tivation. We confirmed that Ifng RNA was induced by activation
of Th1 cells, but not of naive or Th2 cells (Figure 4C, upper panel).
Conversely, Il4was expressed by activated Th2, but not by naive
or Th1 cells (Figure 4C, upper panel). ChIP analysis showed co-
hesins at Th2 HSS3 in naive, Th1, and Th2 cells (Figure 4C, lower
panel). Cohesin binding to HSII within the Ifng coding region ap-
peared to be stronger in Th1 cells than in Th2 cells, consistent
with reports that DNase I sensitivity of HSII is reduced in Th2 cells
(Agarwal and Rao, 1998). Interestingly, cohesin persisted within
the coding region even when high-level Ifng expression was
induced by the acute activation of Th1 cells (Figure 4C, lower
panel). Hence, cohesin binding appears compatible with the
remodeling of the Th2 and Ifng loci and even the high-level ex-
pression of the inducible Ifng gene.
Conservation of Cohesin Site Choice
A majority of HSS are conserved between multiple species and
therefore represent conserved noncoding sequences (CNS),
andmany othologs of human HSS are also HSS inmouse (Craw-
ford et al., 2006). As expectedbased on this relationship between
HSS and conservation, cohesin sites identified by ChIP on chip
often mapped to CNS as defined by VISTA (42.8% of cohesin
sites in pre-B cells and 42% in thymocytes versus an expected
10.7%, p < 109) and the UCSC Genome Browser (34.1% of co-
hesin sites in pre-B cells and 35.5% in thymocytes versus an ex-
pected 6.3%, p < 109) and 49.4% of cohesin sites scored as
CNS when both algorithms were combined (expected 13.2%, p
< 109). Conversely, only 2.3% of CNS were enriched for cohe-
sins, indicating that cohesins bind a select subset of conserved
sequences and HSS. This raises the question whether cohesin
site choice itself is conserved, so that cohesins bind to the
same subset of conserved sequences in different species. We
therefore examined cohesin binding in human 293T cells trans-
fected with 2FLAG-Rad21 or control vector by anti-FLAG ChIP.
Remarkably, 13 of 15 (87%) CNS that bound cohesins in mouse
B3 and VL3 cells also showed robust cohesin signals in human
293T cells (Figure 5), indicating a high degree of conservation in
the placement of cohesins. As a control, we analyzed a sample
of CNSs not associated with cohesins in mouse cells and none
of thesevensites testedboundcohesins inhumancells (Figure5).
Finally, control sites that are neither conserved nor bind cohesins
in mouse cells showed no cohesin binding in human cells. We
conclude that not only do cohesins bind to HSS that are con-
served through evolution but, also, that cohesin site choice itself
is conserved between mouse and human.
Cohesin Recruitment by the Insulator Protein CTCF
Close inspection indicates that the cohesin sites identified in
mouse and human cells are GC rich, in contrast to yeast cohesinsites, which have high AT content (Blat and Kleckner, 1999; La-
loraya et al., 2000; Lengronne et al., 2004; Glynn et al., 2004). We
conducted a motif search using NestedMICA (Down and Hub-
bard, 2005). This approach identified five 12 nt motifs (a–e,
Figure S4) of which motif e was the most frequent, statistically
themost robust, and very similar to the core of theCTCF consen-
sus sequence (Kim et al., 2007) (MotifExplorer score = 1.34,
Figure 6A). Based on this result, we carried out ChIP for CTCF
and found CTCF at 12 of 13 cohesin sites tested in human
293T cells (Figure 6B) and at 14 of 14mouse cohesin sites tested
(Figure S5A). CTCFChIP on chip in B3 pre-B cells identified 1287
CTCF sites, 77.2% of which coincided with cohesin sites we had
identified in B3 cells. Conversely, cohesin colocalized with
65.3% of CTCF sites. Taken together, cohesin and CTCF ChIP
on chip identified a total of 2906 peaks, of which 70.6%mapped
to sites shared by cohesin and CTCF (Figures 6C, S5B, and
S5C).
To explore the functional relationship between cohesin and
CTCF binding, we transfected human 2xFLAG-Rad21 293T cells
with CTCF siRNA oligonucleotides. CTCF depletion did not im-
pair the association of cohesin with chromatin (Figure S6A),
nor did it abolish sister chromatid cohesion (Figure S6B). How-
ever, CTCF depletion did disrupt the positioning of both Rad21
(Figure 7A) and Smc3 (not shown) to specific sites (see
Figure S6C, upper panel for controls). Conversely, RNAi-medi-
ated depletion of the cohesin subunit Rad21 did not affect
CTCF binding to the same sites in 293T cells (Figures 7B and
S6C, lower panel for controls), which demonstrates that cohesin
localization requires CTCF but not vice versa. These results
show that—beyond their colocalization to sites across the ge-
nome—CTCF and cohesin have an important functional relation-
ship where CTCF is required for cohesin recruitment to specific
sites.
One of the best known CTCF-dependent insulators is the 50
HS4 of the chicken beta globin locus, which has been used to
demonstrate CTCF-dependent insulator function in plasmid-
based transfection assays (Recillas-Targa et al., 1999). Two cop-
ies of the 250 bp HS4 insulator reduced the expression of a neo-
mycin (neo) resistance gene when inserted between the SV40
enhancer and promoter elements (pNI-CD) (Recillas-Targa
et al., 1999), while deletion of the insulator resulted in full neo ex-
pression (pNI) (Recillas-Targa et al., 1999). To address whether
cohesins contribute to insulator function in this system, 293T
cells were transfected with insulator or control reporter plasmids
and with siRNA oligonucleotides. As expected, the insulator re-
duced neo expression relative to the control plasmid, and, inter-
estingly, expression was restored not only by siRNA depletion of
CTCF, but also of Rad21 (Figure 7C, knockdown efficiency was
similar to that in Figures 7A and 7B, not shown). These data sug-
gest that, at least in transient transfection assays, cohesins con-
tribute to CTCF-dependent insulator function.
The demonstration that cohesins are recruited by CTCF sug-
gested an explanation for the existence of cell-specific cohesin
sites. Anti-CTCF ChIP showed differential CTCF binding at sev-
eral such sites (Figure 7D, upper panel). Because CTCF prefer-
entially interacts with unmethylated DNA (Bell and Felsenfeld,
2000; Hark et al., 2000) we determined the methylation status
of CpG dinucleotides within cell-specific CTCF/cohesin sites.Cell 132, 422–433, February 8, 2008 ª2008 Elsevier Inc. 427
Figure 4. Cohesin Binding Is Compatible with Locus Remodeling and High-Level Expression of Cytokine Loci
(A) Schematic representation of the Th2 cytokine locus. The proximal and distal sections are represented separately and to different scale. Cohesin localization is
shown for 2xFLAG-Rad21 VL3 cells (dark gray bars) and 2xFLAG-Rad21 BW5147 cells (BW, light gray bars).428 Cell 132, 422–433, February 8, 2008 ª2008 Elsevier Inc.
CTCF motifs within sites shared between B3 and VL3 cells
were largely unmethylated, while CpG methylation correlated
inversely with CTCF and cohesin binding (Figure 7D, lower
panel). Hence, differential CpG methylation patterns in B3
and VL3 cells—be they cell-line specific or indicative of cell lin-
eage and developmental stage—point to an epigenetic contri-
bution to the positioning of cohesins on mammalian chromo-
some arms.
DISCUSSION
SMC proteins and the cohesin, condensin, and SMC5/6 com-
plexes that they form are highly conserved from yeast to mam-
mals. Despite this, our study shows that the mechanism for po-
sitioning cohesins on mammalian chromosome arms is different
from that established in S. cerevisiae (Lengronne et al., 2004;
Glynn et al., 2004). In contrast to yeast, the positioning of mam-
malian cohesins does not appear to be directed by transcription.
Mammalian cohesins were not enriched at intergenic sites of
convergent transcription, and cohesin binding within coding re-
gions was compatible with chromatin remodeling as well as withFigure 5. Evolutionary Conservation of Cohesin Site
Choice
CNSs identified by Vista or UCSC Genome Browser were di-
vided in those that bind cohesins (green) and those that do
not bind cohesins (red) in 2xFLAG-Rad21 mouse B3 and
VL3 cells (top panel). Nonconserved sequences are included
as controls (gray). Genomic positions show chromosome
and base count in kilobases. Human 293T cells were trans-
fected with 2xFLAG-Rad21 or control vector (bottom panel).
Anti-FLAG ChIP and qPCR were used to analyze conserved
sites that bind cohesins in mouse cells (green), conserved
sites that do not associate with cohesins in mouse cells
(red), and nonconserved control sites (gray).
acute transcription. Instead, mammalian cohesin
complexes preferentially localized to a subset of
DNase I hypersensitive sites, many of which were
conserved noncoding sequences. Transgenes
containing cohesin-binding sequences were able
to recruit cohesins to ectopic locations. While
some cohesin sites were preferentially or exclu-
sively present in B3 pre-B cells or in VL3 thymo-
cytes, most were shared. Moreover, the choice of
sites that cohesins bind to was largely conserved
between mouse and human cells. An explanation
for these features was suggested by the result
that, in contrast to S. cerevisiae (Lengronne et al.,
2004; Glynn et al., 2004), mammalian cohesin sites
shared underlying sequence motifs. The prevalent
cohesin sequence motif was highly similar to the
CTCF motif (Kim et al., 2007), and we found that CTCF and co-
hesins colocalize extensively in mammalian cells. Importantly,
loss-of-function experiments demonstrated that CTCF largely
determines the localization of cohesins. Cohesin recruitment
by CTCF provides a mechanism for the selective positioning of
cohesins on mammalian chromosome arms and explains the
preference of cohesins for constitutive HSSwithout classical en-
hancer or promoter function, reflecting features typical of CTCF
sites (Barski et al., 2007; Kim et al., 2007; Birney et al., 2007).
Current array designs exclude repeat-rich heterochromatic re-
gions, and it may be that heterochromatic and, in particular, cen-
tromeric cohesins are recruited via different mechanisms: in S.
pombe, cohesins are recruited to constitutive heterochromatin
via Swi6, a homolog of HP1, which binds to histone H3 methyl-
ated at lysine 9 (H3K9me) as well as to cohesin subunits (Bernard
et al., 2001; Nonaka et al., 2002).
CTCF is notable for its association with vertebrate imprinting
control regions, insulators, and boundary elements, which are
thought to partition the genome into domains that are regulated
independently of each other. Recent studies have shown that
CTCF functionally interacts with the SNF2-like chromodomain(B) Schematic representation of the Ifng locus and cohesin localization in 2xFLAG-Rad21 VL3 cells, 2xFLAG-Rad21 BW5147 cells, and Rad21-3HA transgenic
primary thymocytes.
(C) qRT-PCR (upper panels) shows expression of Il4 (left) only in activated (red bars) Th2 cells, not in naive T cells, Th1 cells, or in resting Th2 cells (blue bars). Ifng
(right) was expressed only in activated (red bars) Th1 cells, not in naive T cells, Th2 cells, or in resting Th1 cells (blue bars). Cohesin sites (lower panels) in the Th2
cytokine locus (left, primer 6 in panel A) and the Ifng locus (right, primer 4 in panel B) in resting (blue bars) and activated (red bars) naive, Th1, and Th2 Rad21-3HA
transgenic primary T cells (n = 3, mean ± SD normalized to Igf2r to account for different ChIP efficiencies in resting and activated T cells).Cell 132, 422–433, February 8, 2008 ª2008 Elsevier Inc. 429
helicase protein CHD8 (Ishihara et al., 2006) and that CTCF and
CHD8 are both required for enhancer blocking activity and insu-
lator function (Ishihara et al., 2006). Similar to our results for co-
hesin, CHD8 became delocalized in cells depleted of CTCF,
while CTCF remained correctly positioned in cells depleted of
CHD8 (Ishihara et al., 2006). Hence, CTCF recruits both CHD8
and cohesin. SNF2 activity was required for cohesin binding to
human ALU repeats (Hakimi et al., 2002), consistent with a possi-
ble role for CHD8 in cohesin recruitment. We have shown that, at
least in transient transfection assays, cohesins contribute to
CTCF-dependent insulator function, as previously demonstratedFigure 6. Colocalization of Cohesin and CTCF
(A) Sequencemotif e was enriched at cohesin sites and is similar to
the 12 core nucleotides of the CTCF consensus (Kim et al., 2007).
(B) Twelve of thirteen cohesin sites in 293T cells (top panel) bind
CTCF (bottom panel, n = 2, mean ± SE); on retrospective analysis,
six sites had a CTCF consensus motif (Kim et al., 2007).
(C) Overlap of cohesin- and CTCF-binding sites in B3 pre-B cells.
ChIP on chip yielded 1287 CTCF sites (see also Figure S5), of
which 77.2% colocalized with Rad21. Conversely, 65.3% of
1619 Rad21 sites colocalized with CTCF. Of 2906 sites in total,
2051 (70.6%) bound Rad21 and CTCF within 1 kb of each other,
543 (18.7%) Rad21 alone, and 287 (9.8%) CTCF alone.
for CHD8 (Ishihara et al., 2006). Taken together with
the phenotypic spectrum of cohesin mutations, these
data suggest that functions previously ascribed to
CTCF are in fact mediated cooperatively by CTCF
and its cofactors (Ishihara et al., 2006; this paper)
and provide a possible rationale for noncanonical co-
hesin functions (Hagstrom and Meyer, 2003; Rollins
et al., 2004; Dorsett, 2006; Strachan, 2005; Horsfield
et al., 2007; Zhang et al., 2007). Differences in DNA
methylation guide CTCF binding and ultimately cohe-
sin recruitment, explaining reports that 5-Aza-cytidine
treatment leads to the appearance of novel cohesin
sites (Hakimi et al., 2002). In this way, cohesin recruit-
ment by CTCF links DNA sequence and epigenetic
state.
EXPERIMENTAL PROCEDURES
Cells, Vectors, and Transgenic Mice
MSCV-based 2FLAG-Rad21-IRES-puromycin retroviral vectors
were constructed and transduced into B3 (Brown et al., 1997),
VL3-3M2 (VL3; Groves et al., 1995), BW5147 (ATCC), primary
pre-B cell lines, Ableson-transformed pre-B cells transgenic for
Vpreb1/Igll1 (Lundgren et al., 2000), or 293T cells as described
(Thompson et al., 2007). Transgenic mice were derived by
pronuclear injection of VA-Rad21-3HA based on the human
CD2 promoter and 30 locus control region (LCR) (Zhumabekov
et al., 1995) under a Project License granted by the Home Office,
UK.
Protein and RNA Detection
Nuclear extracts were fractionated into soluble and chromatin
bound and immunoblotted as described (Me´ndez and Stillman,
2000). For silver staining, acrylamide gels were washed in 50%430 Cell 132, 422–433, February 8, 2008 ª2008 Elsevier Inc.methanol, 5% methanol, 0.33 mM dithiothreitol, incubated in 0.1% (w/v)
AgNO3 for 20 min, rinsed in H2O, and developed in 3% w/v Na2CO3,
and 0.02% v/v formaldehyde. The reaction was stopped with citric acid
monohydrate. Gene expression data were from Affymetrix 430/2.0 arrays
or qRT-PCR Ywhaz forward CGTTGTAGGAGCCCGTAGGTCAT, reverse
TCTGGTTGCGAAGCATTGGG; Ubc forward AGGAGGCTGATGAAG
GAGCTTGA, reverse TGGTTTGAATGGATACTCTGCTGGA; Il4 forward AAC-
GAGGTCACAGGAGAAGG, reverse TCTGTGGTGTTCTTCGTTGCT; Ifng
forward CTGAGACAATGAACGCTACAC, reverse TTTCTTCCACATCTATGCC
AC; Igf2ra forward CAAGCACTTTCAAGGTTACTCGG, reverse GGAT
CACCATTCACATAACTCAG; Igf2rb forward GACCAAGTCTGTTTCTTC
CACC, reverse CATCCTCAAAGTCCACACCCAGAG; and neo forward
TCCCCTCAGAAGAACTCGTCA, reverse TCCTGCCGAGAAAGTATCCATC.
Figure 7. Functional Relationship between Cohe-
sin and CTCF
(A) Cohesin ChIP in 2xFLAG-Rad21 293T cells transfected
with control (gray bars) or CTCF siRNA oligonucleotides
(black bars, n = 2, mean ± SE). Histone H3 ChIP is shown
in Figure S6C, upper panel as a positive control.
(B) CTCF ChIP in 293T cells transfected with control (gray
bars) or Rad21 RNAi oligonucleotides (black bars, n = 2 ±
SE). Histone H3 ChIP is shown in Figure S6C, lower panel.
(C) CTCF and cohesin contribute to insulator activity in
transient transfection assays. 293T cells were transfected
with either control (left) or chicken beta globin core insula-
tor plasmid (right) and 24 hr later with control siRNA
(black), CTCF siRNA (dark gray), or Rad21 siRNA (light
gray). Two days later neo expression was determined by
qRT-PCR and normalized to expression from the control
plasmid (n = 3, mean ± SD p values were determined by
comparing the results of control siRNA with CTCF siRNA
and control siRNA with Rad21 siRNA by Student’s t test
with Bonferoni correction). Cotransfection of a GFP plas-
mid confirmed >80% transfection efficiency (not shown).
(D) Differential CTCF binding to cell-specific cohesin sites.
Shared and cell-specific cohesin sites (Figure 3A) were as-
sessed by ChIP for CTCF binding in B3 (dark bars) and VL3
(light bars) cells (top panel). Methylation of CpG dinucleo-
tides was analyzed by bisulphite sequencing of B3 and
VL3 DNA (bottom panel). Methylated CpG dinucleotides
are indicated by filled circles and unmethylated CpG dinu-
cleotides by open circles. Arrows mark the position of pre-
dicted CTCF-binding sites and chromosomal positions
are indicated (in kilobases).Cell 132, 422–433, February 8, 2008 ª2008 Elsevier Inc. 431
ChIP, qPCR, Amplification, and Genomic Tiling Arrays
Nuclear extracts from cells fixed with 1% formaldehyde (10 min, 37C)
were sonicated and immunoprecipitated with protein A sepharose CL-4B
beads (Amersham) and rabbit anti-Rad21 (Hakimi et al., 2002), anti-
Smc3 (the kind gift of J.-M. Peters), anti-CTCF (Upstate 07729), mouse
anti-FLAG (Sigma F3165), or mouse anti-HA (Covance MMS-101R) fol-
lowed by rabbit anti-mouse IgG (Dako Z0259). qPCR primers were de-
signed with Primer Express (Applied Biosystems) and tested in silico
(http://genome.ucsc.edu). qPCR conditions were the following: 15 min at
95C followed by 15 s at 94C, 30 s at 60C, 30 s at 72C, and fluores-
cence was read at 72, 74, 76, and 78C (Opticon DNA engine, MJ Re-
search). Melting curves were determined and data analyzed with Opticon
Monitor 3 software (MJ Research). For hybridization to custom tiling arrays
with 380,000 features at 100 bp resolution (Nimblegen), ChIP samples
were amplified following the manufacturers’ instructions, and results
were analyzed with PeakFinder software (NimbleGen) applying windowed
threshold detection (window size 250 bp, peak threshold 20% for B3 cells
and 10% for VL3 cells). Genomic position refers to mouse build 33 of May
2004. Cohesin motifs were identified with NestedMICA (Down and Hub-
bard, 2005) and evaluated with MotifExplorer (http://www.sanger.ac.uk/
Software/analysis/nmica/mxt.shtml).
RNAi
RNAi oligonucleotides were designed and transfected as suggested by the
manufacturer (Dharmacon).
DNase I Hypersensitivity Assays
Permeabilised nuclei (2 3 107/ml) were incubated with increasing amounts of
DNase I (Roche) in 50 mM Tris pH 8, 100 mM NaCl, 3 mM MgCl2, 0.15 mM
spermine, 0.5 mM spermidine, 1 mM CaCl2. Digestion was stopped with
EDTA after 5min, DNA was PCR amplified and products quantified with Quan-
tity One (BioRad).
Metaphase Spreads and Immunofluorescence Staining
293T cells were treated with 280 mg/ml thymidine, released, blocked in meta-
phase (0.2 mg/ml demecolcine, 1 hr), swollen in 75 mM K+Cl, fixed in metha-
nol/acetic acid, and stained with DAPI.
Insulator Assays
293T cells were transfected with 2 mg of pNI control plasmid or pNI-CD isulator
plasmid (Recillas-Targa et al., 1999), a GFP plasmid to monitor transfection
efficiency, and, 24 hr later, with the indicated siRNA oligonucleotides. RNA
was isolated after 72 hr.
Bisulphite Sequencing
Genomic DNA (1.5 mg) was bisulfite converted using EZ-DNA Methylation Kit
(Zymo Research, D5001) and 25 ng of bisulfite-converted DNA was amplified
with gene-specific PCR primers (http://www.urogene.org/methprimer). Gel-
purified products were cloned into pCRII vector (Invitrogen, 45-0007), and
plasmid DNA from individual clones was miniprepped for sequencing.
Supplemental Data
Supplemental Data include six figures and can be found with this article online
at http://www.cell.com/cgi/content/full/132/3/422/DC1/.
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